Page last updated: 2024-10-16

carbamates and Osteosarcoma

carbamates has been researched along with Osteosarcoma in 2 studies

Osteosarcoma: A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed)

Research Excerpts

ExcerptRelevanceReference
"Apcin is a novel cell‑permeable molecule that blocks the interaction between APC/C and Cdc20."5.48Cdc20 inhibitor apcin inhibits the growth and invasion of osteosarcoma cells. ( Gao, Y; Shang, G; Wang, Y; Zhang, B, 2018)
"Apcin is a novel cell‑permeable molecule that blocks the interaction between APC/C and Cdc20."1.48Cdc20 inhibitor apcin inhibits the growth and invasion of osteosarcoma cells. ( Gao, Y; Shang, G; Wang, Y; Zhang, B, 2018)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gao, Y1
Zhang, B1
Wang, Y1
Shang, G1
Pratt, CB1
Wang, JJ1

Other Studies

2 other studies available for carbamates and Osteosarcoma

ArticleYear
Cdc20 inhibitor apcin inhibits the growth and invasion of osteosarcoma cells.
    Oncology reports, 2018, Volume: 40, Issue:2

    Topics: Apoptosis; Bcl-2-Like Protein 11; Carbamates; Cdc20 Proteins; Cell Line, Tumor; Cell Proliferation;

2018
Acetylenic carbamate in childhood cancer.
    Cancer, 1971, Volume: 27, Issue:5

    Topics: Acute Disease; Adolescent; Age Factors; Alkynes; Blood Cell Count; Bone Neoplasms; Carbamates; Child

1971